03/27/2026
Emerging research is exploring how GLP-1 therapies—commonly used in type 2 diabetes—may benefit people with type 1 diabetes.
A new Cleveland Clinic analysis suggests these medications could help improve blood sugar control and support weight management. However, because they’re not yet approved for type 1 diabetes, careful monitoring and more research are still needed.
What does this mean for the future of diabetes care? 👇
https://consultqd.clevelandclinic.org/new-analysis-examines-long-term-outcomes-of-glp-1-therapies-in-type-1-diabetes
A retrospective analysis finds lower mortality rates and fewer hospital visits among patients with Type 1 diabetes using GLP-1 Therapies